about
acp Best Practice No 169. Evidence based pathology: squamous carcinoma of the hypopharynxERK1/2 and p38α/β signaling in tumor cell quiescence: opportunities to control dormant residual disease.Multiparameter analysis, including EMT markers, on negatively enriched blood samples from patients with squamous cell carcinoma of the head and neckMicroenvironments dictating tumor cell dormancyRegulation of tumor cell dormancy by tissue microenvironments and autophagy.Models, mechanisms and clinical evidence for cancer dormancy.Significance of circulating tumor cells in patients with squamous cell carcinoma of the head and neck: initial resultsComputational identification of a p38SAPK-regulated transcription factor network required for tumor cell quiescenceEarly postoperative epidermal growth factor receptor inhibition: safety and effectiveness in inhibiting microscopic residual of oral squamous cell carcinoma in vivo.Effect of surgical intervention on circulating tumor cells in patients with squamous cell carcinoma of the head and neck using a negative enrichment technology.TGF-β2 dictates disseminated tumour cell fate in target organs through TGF-β-RIII and p38α/β signalling.Circulating tumor cells in head and neck cancer: clinical impact in diagnosis and follow-up.Squamous cell carcinoma of the oral cavity and circulating tumour cells.Diagnostic and Prognostic Value of Circulating Tumor Cells in Head and Neck Squamous Cell Carcinoma: a systematic review and meta-analysis.Relapse status as a prognostic factor in patients receiving salvage surgery for recurrent or residual nasopharyngeal cancer after definitive treatment.Intrinsic TGF-β2-triggered SDF-1-CXCR4 signaling axis is crucial for drug resistance and a slow-cycling state in bone marrow-disseminated tumor cells.Discordance of genetic alterations between primary head and neck tumors and corresponding metastases associated with mutational status of the TP53 gene.Assessment and clinical significance of micrometastases in lymph nodes of head and neck cancer patients detected by E48 (Ly-6D) quantitative reverse transcription-polymerase chain reaction.Identification of circulating tumor cells: a prognostic marker in squamous cell carcinoma of the head and neck?Single-cell genomic analysis of head and neck squamous cell carcinoma[In vitro effect of taurolidine on squamous cell carcinoma in the oral cavity].Immunohistochemical and FISH analysis of EGFR and its prognostic value in patients with oral squamous cell carcinoma.
P2860
Q35057448-CABC7F9F-605E-4A5A-B313-7D565E6A3F8BQ35579435-C9BE639D-5EF3-423B-8434-2F48D51A9376Q36120034-1E8C9D6D-D7A7-424C-917B-B094F1FA70C9Q36450759-289C399C-7D7C-47A2-B394-062A64E98131Q36836555-87311369-763C-4923-A822-3D150E4B87D0Q36844303-85142606-4180-41D2-A36E-10C824183052Q37087791-925999AE-86B9-4E8B-800B-AD2A65763D72Q37288325-A63E3050-601F-4F36-A0FC-862F1EDC4F45Q37331972-4F8DAEDC-C553-47C5-986F-8A9C065777DFQ37427188-D6C7065E-F1ED-4A19-8360-3205D788C577Q37735525-5D2B442F-5EF2-4241-83A7-E9AB220797CEQ38081372-97C9BEA8-845A-4EA9-8CDB-3B6C5519D594Q38211869-01750388-AE9C-46E5-9722-C16DA4930EE0Q38718528-53FC93B6-F4D7-468D-979B-97710A5B3F4CQ38797778-A64FCB3C-D19D-4B2A-83A0-442F05BD5D80Q38928700-3E56BF91-C2E7-4A00-9F41-E4E15F647FD0Q39122496-326AE875-DA0E-4AA7-871B-BEF3ABE76021Q39125674-85969632-D611-453C-93BE-C4065827F2CDQ39764210-52E45FC0-584B-4760-9569-E8C1A4AB2CEFQ42700676-24BEC194-B297-48DA-AF2D-206D3E8A7288Q44381913-7FE9AB14-DC1C-400F-A099-B301DB32E9AAQ54410118-8C767197-4E34-4D77-B199-5DCCC923368A
P2860
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Minimal residual disease in head and neck cancer.
@ast
Minimal residual disease in head and neck cancer.
@en
type
label
Minimal residual disease in head and neck cancer.
@ast
Minimal residual disease in head and neck cancer.
@en
prefLabel
Minimal residual disease in head and neck cancer.
@ast
Minimal residual disease in head and neck cancer.
@en
P356
P1476
Minimal residual disease in head and neck cancer.
@en
P2093
Brakenhoff RH
P2888
P304
P356
10.1023/A:1006268621730
P577
1999-01-01T00:00:00Z
P6179
1004489742